Mosaic Immunoengineering IncOTC Pink - Current Information:CPMV
- LAST PRICE1.0000
- TODAY'S CHANGE (%)0.0100 (1.0101%)
- Bid / Lots0.6010/ 10
- Ask / Lots1.1100/ 1
- Open / Previous Close0.8000 / 0.9900
- Day Range
- 52 Week Range
- Volume245
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CPMV |
|---|---|---|
| 10:36 ET | 141 | 0.8 |
| 12:55 ET | 100 | 1 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mosaic Immunoengineering Inc | 7.2M | -6.8x | --- |
Klotho Neurosciences Inc | 7.2M | -1.6x | --- |
Galecto Inc | 7.3M | -0.3x | --- |
Alterola Biotech Inc | 7.3M | -3.0x | --- |
Edesa Biotech Inc | 7.5M | -1.1x | --- |
Purple Biotech Ltd | 6.8M | 0.0x | --- |
Company Information
Mosaic ImmunoEngineering, Inc. is a development-stage biotechnology company focused on advancing cancer therapies for areas of high unmet medical need. The Company has advanced an early-stage product candidate, MIE-101, that is based on a naturally occurring plant virus licensed from Case Western Reserve University (CWRU). Its product candidate, MIE-101, is based on a naturally occurring plant virus known as Cowpea mosaic virus (CPMV). The product is injected directly into a tumor and can act as an in-situ vaccine using markers of the injected tumor as the target which results in the activation of an immune response against the primary tumor and to prime systemic anti-tumor immunity, while reversing immunosuppressive signals in the tumor microenvironment (TME). In addition, the Company is pursuing new product candidates and platforms to expand its pipeline based on an understanding of immunotherapies and its license agreements with University of California San Diego.
Contact Information
- Headquarters
- 9114 ADAMS AVE., #202HUNTINGTON BEACH, CA, United States 92646
- Phone
- 657-208-0890
- Fax
- 302-645-1280
Executives
- Director
- Steven King
- Director
- Paul Lytle
- Independent Director
- Robert Baffi
- Independent Director
- Robert Garnick
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 7.2M |
Mosaic Immunoengineering Inc does not pay a dividend. | |
Beta | 0.16 |
EPS | $-0.15 |
Book Value | $-0.81 |
P/E Ratio | -6.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
